NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmalundensis AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
520
|
434
|
401 |
| Earnings before taxes |
-4,457
|
-3,108
|
-2,544 |
| EBITDA |
-2,896
|
-2,474
|
-2,144 |
| Total assets |
11,106
|
8,286
|
8,103 |
| Current assets |
2,830
|
587
|
1,107 |
| Current liabilities |
2,688
|
2,238
|
909 |
| Equity capital |
3,200
|
1,661
|
3,119 |
| - share capital |
2,137
|
1,408
|
1,354 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
28.8%
|
20.0%
|
38.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-35.4%
|
-32.3%
|
-26.4% |
| Current ratio |
105.3%
|
26.2%
|
121.8% |
| Return on equity (ROE) |
-139.3%
|
-187.1%
|
-81.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.